Trial Profile
Gemcitabine for Classical Hodgkin's Lymphoma.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2012
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Bleomycin; Dacarbazine; Doxorubicin; Vinblastine
- Indications Hodgkin's disease
- Focus Adverse reactions; Therapeutic Use
- 21 May 2012 Planned End Date 31 Dec 2011 added as reported by Chinese Clinical Trial Register record.
- 20 Dec 2011 New trial record